Literature DB >> 3766667

Comparison of quantitative testing with the Octopus, Humphrey, and Tübingen perimeters.

R P Mills, R H Hopp, S M Drance.   

Abstract

Meridional threshold testing was used to compare the quantitative abilities of the Octopus 201, Humphrey 620, and Tübingen perimeters. In 40 patients with mild to moderate glaucomatous visual field defects, the perimeters provided comparable results, and only small differences could be identified. Manual Tübingen testing identified slightly fewer defects, and scotomas were plotted as narrower and shallower than on the two automated devices, which were nearly equivalent in performance.

Entities:  

Mesh:

Year:  1986        PMID: 3766667     DOI: 10.1016/0002-9394(86)90080-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

1.  Full threshold versus quantification of defects for visual field testing in glaucoma.

Authors:  W C Stewart; M B Shields; A R Ollie
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

2.  The influence of stimulus parameters on the visual field indices by automated projection perimetry.

Authors:  M Dengler-Harles; J M Wild; M D Cole; E C O'Neill
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-06       Impact factor: 3.117

3.  Short wavelength automated perimetry in age related maculopathy.

Authors:  A Remky; K Lichtenberg; A E Elsner; O Arend
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

4.  Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension.

Authors:  Boel Bengtsson; Anders Heijl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-09       Impact factor: 3.117

5.  Effect of Cognitive Demand on Functional Visual Field Performance in Senior Drivers with Glaucoma.

Authors:  Viswa Gangeddula; Maud Ranchet; Abiodun E Akinwuntan; Kathryn Bollinger; Hannes Devos
Journal:  Front Aging Neurosci       Date:  2017-08-30       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.